Hangzhou Tigermed Consulting Co., Ltd. (3347.HK) HKSE

57.55

-0.85(-1.46%)

Updated at August 18 04:09PM

Currency In HKD

Valuation

Market Cap25.02B
Enterprise Value25.6B
P/E Ratio180.39
PEG Ratio-10.6
Price/Sales Ratio7.89
Price/Book Ratio2.95
Enterprise/Revenue8.13
Enterprise/EBITDA92.45

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterMarch 31, 2025

Profitability

Profit Margin0.05
Operating Margin0.07

Management Effectiveness

Return On Assets0.01
Return On Equity0.02

Income Statement

Revenue6.6B
Revenue/Share7.46
Gross Profit2.24B
EBITDA1.13B
Net Income405.14M
Diluted EPS0.47

Balance Sheet

Total Cash1.68B
Total Cash/Share1.92
Total Debt2.85B
Total Debt/Equity0.15
Current Ratio1.62
Book Value Per Share27.45

Price History

52-Week Change78.73
52-Week High60.6
52-Week Low22.3
Moving Average 50 Days46.3
Moving Average 200 Days35.15

Statistics

Average Volume5.29M
Shares Outstanding1.09B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.3
Trailing Annual Dividend Yield0.43
Payout Ratio1.82
Last Split FactorN/A
Last Split DateN/A